Literature DB >> 32770458

Ultrasound-assisted, low-solvent and acid/base-free synthesis of 5-substituted 1,3,4-oxadiazole-2-thiols as potent antimicrobial and antioxidant agents.

Elahe Yarmohammadi1, Hamid Beyzaei2, Reza Aryan1, Ashraf Moradi1.   

Abstract

One of the goals of green chemistry is to use environmentally friendly solvents or remove and reduce the volume of harmful spent solvents. In this study, a novel process for the synthesis of 5-substituted 1,3,4-oxadiazole-2-thiol derivatives was proposed via ultrasound-assisted reaction of aryl hydrazides with CS2 (1:1 molar ratio) in some drops of DMF in the absence of basic or acidic catalysts. They were produced in good to excellent yields under easy workup and purification conditions. In order to prove the usefulness of the prepared compounds, their antioxidant, antibacterial, and antifungal potentials were screened by DPPH free radical scavenging, serial twofold microdilution and streak plate methods. Acceptable to significant inhibitory activities were observed with synthesized heterocycles. The results showed that 5-(4-fluorophenyl)-1,3,4-oxadiazole-2-thiol (3c) is an broad-spectrum antimicrobial agent. Many of them displayed remarkable antioxidant properties comparable to standard controls (ascorbic acid and α-tocopherol). Synthesized 1,3,4-oxadiazoles are also potent candidates to treat cancer, Parkinson, inflammatory, and diabetes diseases. Eighteen 5-substituted 1,3,4-oxadiazole-2-thiol derivatives as potent antimicrobial and antioxidant agents were prepared via a new, efficient and green procedure.
© 2020. Springer Nature Switzerland AG.

Entities:  

Keywords:  1,3,4-Oxadiazole; Antibacterial; Antifungal; Antioxidant; Green synthesis; Ultrasound irradiation

Mesh:

Substances:

Year:  2020        PMID: 32770458     DOI: 10.1007/s11030-020-10125-y

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  27 in total

1.  1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities.

Authors:  Sampark S Thakkar; Parth Thakor; Hiren Doshi; Arabinda Ray
Journal:  Bioorg Med Chem       Date:  2017-05-27       Impact factor: 3.641

2.  Cu(II) catalyzed imine C-H functionalization leading to synthesis of 2,5-substituted 1,3,4-oxadiazoles.

Authors:  Srimanta Guin; Tuhin Ghosh; Saroj Kumar Rout; Arghya Banerjee; Bhisma K Patel
Journal:  Org Lett       Date:  2011-10-18       Impact factor: 6.005

3.  Direct Annulation of Hydrazides to 1,3,4-Oxadiazoles via Oxidative C(CO)-C(Methyl) Bond Cleavage of Methyl Ketones.

Authors:  Qinghe Gao; Shan Liu; Xia Wu; Jingjing Zhang; Anxin Wu
Journal:  Org Lett       Date:  2015-06-02       Impact factor: 6.005

4.  Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis.

Authors:  Vitthal B Makane; Vagolu Siva Krishna; Eruva Vamshi Krishna; Manjulika Shukla; Balakrishnan Mahizhaveni; Sunil Misra; Sidharth Chopra; Dharmarajan Sriram; Vijayan N Azger Dusthackeer; Haridas B Rode
Journal:  Future Med Chem       Date:  2019-03-20       Impact factor: 3.808

5.  I2-mediated oxidative C-O bond formation for the synthesis of 1,3,4-oxadiazoles from aldehydes and hydrazides.

Authors:  Wenquan Yu; Gang Huang; Yueteng Zhang; Hongxu Liu; Lihong Dong; Xuejun Yu; Yujiang Li; Junbiao Chang
Journal:  J Org Chem       Date:  2013-10-08       Impact factor: 4.354

6.  Synthesis and evaluation of some new 1,3,4-oxadiazoles bearing thiophene, thiazole, coumarin, pyridine and pyridazine derivatives as antiviral agents.

Authors:  Mohammed Albratty; Karam Ahmed El-Sharkawy; Hassan Ahmed Alhazmi
Journal:  Acta Pharm       Date:  2019-06-01       Impact factor: 2.230

7.  Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer.

Authors:  K Miller; J W Moul; M Gleave; K Fizazi; J B Nelson; T Morris; F E Nathan; S McIntosh; K Pemberton; C S Higano
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-02-05       Impact factor: 5.554

8.  Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years.

Authors:  Sharon Nachman; Nan Zheng; Edward P Acosta; Hedy Teppler; Brenda Homony; Bobbie Graham; Terence Fenton; Xia Xu; Larissa Wenning; Stephen A Spector; Lisa M Frenkel; Carmelita Alvero; Carol Worrell; Edward Handelsman; Andrew Wiznia
Journal:  Clin Infect Dis       Date:  2013-10-21       Impact factor: 9.079

9.  Synthesis and cytotoxic evaluation of some quinazolinone- 5-(4-chlorophenyl) 1, 3, 4-oxadiazole conjugates.

Authors:  Farshid Hassanzadeh; Hojjat Sadeghi-Aliabadi; Elham Jafari; Azadeh Sharifzadeh; Nasim Dana
Journal:  Res Pharm Sci       Date:  2019-10-04

10.  Pharmacokinetic evaluation, molecular docking and in vitro biological evaluation of 1, 3, 4-oxadiazole derivatives as potent antioxidants and STAT3 inhibitors.

Authors:  Rashmin Khanam; Iram I Hejazi; Syed Shahabuddin; Abdul R Bhat; Fareeda Athar
Journal:  J Pharm Anal       Date:  2018-12-07
View more
  3 in total

1.  Synthesis, carbonic anhydrase inhibition, anticancer activity, and molecular docking studies of 1,3,4-oxadiazole derivatives.

Authors:  Balasaheb D Vanjare; Nam Gyu Choi; Young Seok Eom; Hussain Raza; Mubashir Hassan; Ki Hwan Lee; Song Ja Kim
Journal:  Mol Divers       Date:  2022-03-28       Impact factor: 2.943

Review 2.  Comparative Study of the Synthetic Approaches and Biological Activities of the Bioisosteres of 1,3,4-Oxadiazoles and 1,3,4-Thiadiazoles over the Past Decade.

Authors:  Rana M El-Masry; Hanan H Kadry; Azza T Taher; Sahar M Abou-Seri
Journal:  Molecules       Date:  2022-04-22       Impact factor: 4.927

Review 3.  Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives.

Authors:  Teresa Glomb; Piotr Świątek
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.